Cue Health Profit Margin 2020-2023 | HLTH
Current and historical gross margin, operating margin and net profit margin for Cue Health (HLTH) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Cue Health net profit margin as of December 31, 2023 is -526.48%.
| Cue Health Annual Profit Margins |
|---|
| Cue Health Quarterly Profit Margins |
|---|
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.022B | $0.071B |
| Cue Health Inc. is a health technology company. It offers individuals, enterprises, government agencies and healthcare provides access to lab-quality diagnostic testing at home, at work or at the point-of-care, all in a device. Cue Health Inc. is headquartered in San Diego. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GE HealthCare Technologies (GEHC) | United States | $36.275B | 19.92 |
| Inspire Medical Systems (INSP) | United States | $7.566B | 0.00 |
| Axonics (AXNX) | United States | $3.432B | 0.00 |
| 10x Genomics (TXG) | United States | $3.275B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $3.196B | 0.00 |
| Azenta (AZTA) | United States | $2.979B | 242.82 |
| Olink Holding AB (publ) (OLK) | Sweden | $2.861B | 0.00 |
| Enovis (ENOV) | United States | $2.812B | 20.84 |
| Hims & Hers Health (HIMS) | United States | $2.412B | 0.00 |
| Privia Health (PRVA) | United States | $2.224B | 98.63 |
| Schrodinger (SDGR) | United States | $1.712B | 0.00 |
| Omnicell (OMCL) | United States | $1.384B | 47.83 |
| Phreesia (PHR) | United States | $1.259B | 0.00 |
| Definitive Healthcare (DH) | United States | $0.828B | 0.00 |
| Standard BioTools (LAB) | United States | $0.728B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.643B | 0.00 |
| Talkspace (TALK) | United States | $0.538B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.383B | 0.00 |
| Pulmonx (LUNG) | United States | $0.378B | 0.00 |
| Clover Health Investments (CLOV) | United States | $0.344B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.326B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.202B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.196B | 0.00 |
| American Well (AMWL) | United States | $0.165B | 0.00 |
| Outset Medical (OM) | United States | $0.162B | 0.00 |
| Augmedix (AUGX) | United States | $0.133B | 0.00 |
| MSP Recovery (LIFW) | United States | $0.125B | 0.00 |
| TruBridge (TBRG) | United States | $0.125B | 5.33 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.108B | 0.00 |
| 111 (YI) | China | $0.096B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.071B | 0.00 |
| SHL Telemedicine (SHLT) | Israel | $0.068B | 0.00 |
| HeartBeam (BEAT) | United States | $0.058B | 0.00 |
| Zepp Health (ZEPP) | China | $0.053B | 0.00 |
| Movano (MOVE) | United States | $0.046B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.044B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.034B | 0.00 |
| Akili (AKLI) | United States | $0.032B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.024B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.019B | 0.00 |
| CareCloud (CCLD) | United States | $0.018B | 0.00 |
| ETAO (ETAO) | United States | $0.016B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.015B | 0.00 |
| Biotricity (BTCY) | United States | $0.012B | 0.00 |
| Transgenomic (PRPO) | United States | $0.009B | 0.00 |
| Syra Health (SYRA) | United States | $0.008B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.007B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.006B | 0.00 |
| HeartSciences (HSCS) | United States | $0.006B | 0.00 |
| Zhongchao (ZCMD) | China | $0.003B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| Centogene (CNTG) | Germany | $0.000B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |